GUJ.THEMIS. share price has zoomed 8% and is presently trading at Rs 329.8.
Meanwhile, the BSE HEALTHCARE index is at 42,400.6 (up 0.7%).
Among the top gainers in the BSE HEALTHCARE index today are GRANULES INDIA (up 3.8%) and ERIS LIFESCIENCES (up 3.3%).
ALKEM LABORATORIES (down 0.5%) and Cadila Healthcare (down 0.1%) are among the top losers today.
Over the last one year, GUJ.THEMIS. has moved up from Rs 131.9 to Rs 329.8, registering a gain of Rs 197.9 (up 150.0%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,951.5 to 42,400.6, registering a gain of 46.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 176.2%), SUVEN PHARMACEUTICALS (up 125.4%) and Glenmark Pharma (up 97.5%).
The BSE Sensex is at 78,067.9 (up 0.9%).
The top gainers among the BSE Sensex today are M&M (up 3.1%) and Tech Mahindra (up 2.3%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.
In the meantime, NSE Nifty is at 23,688.7 (up 1.0%). M&M and Trent are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,675.9 to 78,067.9, registering a gain of 12,392.0 points (up 18.9%).
GUJ.THEMIS. net profit fell 15.8% YoY to Rs 106 million for the quarter ended September 2024, compared to a profit of Rs 125 million a year ago. Net sales declined 12.2% to Rs 347 million during the period as against Rs 395 million in July-September 2023.
For the year ended March 2024, GUJ.THEMIS. reported 2.1% increase in net profit to Rs 592 million compared to net profit of Rs 580 million during FY23. Revenue of the company grew 14.4% to Rs 1,698 million during FY24.
The current Price to earnings ratio of GUJ.THEMIS., based on rolling 12 month earnings, stands at 68.2.
Equitymaster requests your view! Post a comment on "GUJ.THEMIS. Gains 8%; BSE HEALTHCARE Index Up 0.7%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!